Melanotan 2 Dosage Guide (10mg)

Research suggests Melanotan 2 may increase skin pigmentation and support tanning responses even with lower UV exposure. In many studies and reports, visible tanning effects started becoming noticeable after around 5–10 daily injections during the initial loading phase. Some users also report increased libido or spontaneous erections due to melanocortin receptor activity. After the loading phase, lower maintenance dosing is often used to help maintain pigmentation levels over time.

The most common side effects are nausea, facial flushing, increased body warmth, reduced appetite, mild fatigue, and injection-site irritation such as redness or stinging. These effects are usually more noticeable at higher doses or during rapid dose increases.

There are also important safety considerations. Melanotan 2 is not FDA-approved and remains an investigational research compound. Higher doses may increase the risk of stronger cardiovascular or stimulant-like effects, including temporary increases in heart rate and blood pressure. The peptide may also darken freckles or existing moles, which is why monitoring skin changes carefully is important. Research on long-term safety is still limited, so conservative dosing and cautious use are strongly recommended.

• Start: 200–250 mcg daily, increasing by 100–250 mcg every 1–2 weeks as tolerated
• Target: 500–1000 mcg daily by around Weeks 4–8
• Frequency: Once daily (subcutaneous) during the loading phase
• Cycle Length: Typically 6–8 weeks for the initial tanning phase
• Maintenance: After loading, many protocols switch to 500–1000 mcg once or twice weekly to help maintain pigmentation
• Timing: Any consistent time works; rotate injection sites regularly to help reduce irritation

• Lyophilized: Store at −20°C or colder, dry and out of light — good for up to 24 months
• Reconstituted: Keep in the fridge at 2–8°C, use within 4 weeks
• Let vials come to room temp before opening to avoid condensation getting inside

Use a fresh sterile insulin syringe every time and dispose of it properly in a sharps container. Rotate injection sites (abdomen, thighs, upper arms) to avoid irritation and buildup. If your dose runs over 10 mg with a 1.0 mL mix, you’ll need multiple vials to hit the volume, and if total volume goes past 1.0 mL, split it into two injections at different sites for better absorption. Inject slowly and give it a few seconds before pulling out to make sure the full dose is delivered. Keep a simple log of dose, date, and injection sites so nothing drifts, and most important, titrate up gradually, don’t rush it or skip steps unless you want your gut to push back.

• Wipe the vial stopper and injection site with alcohol and let it dry fully
• Pinch a small skinfold and insert the needle at 45–90° into subcutaneous tissue
• Don’t aspirate, just inject slow and steady
• If volume goes over 1.0 mL, split into two injections at different sites (e.g. left/right abdomen)
• Rotate sites each time (abdomen is go-to, but thighs and upper arms work too) to avoid irritation and buildup
• After injecting, wait a few seconds before pulling out to make sure the full dose goes in
• Dispose of syringes straight away in a proper sharps container

For safer and more consistent results, use proper sun protection even if combining Melanotan 2 with UV exposure, since too much UV still increases skin damage and skin cancer risk. Staying hydrated is also important, especially if nausea or appetite suppression occurs during dosing. Regularly check your skin and moles for any unusual changes, darkening, or new spots, and seek medical advice if anything changes noticeably. Keeping doses conservative and sticking closely to the protocol is important, as higher doses increase the risk of stronger side effects and unwanted reactions.

This content is for educational and research awareness purposes only, not medical advice, diagnosis, or treatment. Melanotan 2 is an investigational compound and is not approved for clinical use. All information is drawn from published research and clinical trial data and is not intended to promote or guide off-label or human use.